World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
60
Citations
32927
World Ranking
11652
National Ranking
5012

Daniel J. Capon publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Daniel J. Capon sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 113 publications — 9th percentile

9% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Daniel J. Capon D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Daniel J. Capon sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 60 D-Index — 41st percentile

41% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Daniel J. Capon is a researcher primarily affiliated with LabCorp in the United States. Their work spans several key areas within medicine, focusing on oncology, radiology, nuclear medicine and imaging, infectious diseases, immunology, and cardiology and cardiovascular medicine.

Their recent papers include studies published between 2021 and 2025, addressing both immunological therapies and infectious disease challenges. Notable publications are:

  • "Mouse Antibodies with Activity Against the SARS-CoV-2 D614G and B.1.351 Variants" (2021, bioRxiv, Cold Spring Harbor Laboratory)
  • "Topologically engineered antibodies and Fc-fusion proteins: a new class of multifunctional therapeutic candidates for SARS-CoV-2, cancer, and other disease" (2022, bioRxiv, Cold Spring Harbor Laboratory)
  • "Abstract 2730: Beyond antibodies and CAR-T: Topologically-engineered, super-dimeric antibody-like molecules with dual Fc domains for trispecific, bivalent targeting of CD19, CD20, and Fcgamma receptors" (2024, Cancer Research)

Other relevant publications in which they are involved include recent work in The Journal of Rheumatology and Scientific Reports focusing on antibody-like molecules for targeting B cells and enhancing immune effector functions.

Daniel J. Capon's research concentrates on several themes within immunology and oncology, including:

  • Monoclonal and Polyclonal Antibodies Research
  • CAR-T cell therapy research
  • SARS-CoV-2 and COVID-19 Research
  • T-cell and B-cell Immunology
  • COVID-19 Clinical Research Studies
  • Viral Infections and Immunology Research
  • HER2/EGFR in Cancer Research

Frequent co-authors collaborating with Capon include Brendon Frank, Nelson L.S. Chan, Marina E. Fomin, Ursula Edman, and Larisa Troitskaya. These collaborations have contributed to a consistent body of work noted in multiple high-profile scientific venues.

Capon's work has been published across a variety of journals and repositories, with repeated appearances in:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Scientific Reports
  • Cancer Research
  • The Journal of Rheumatology
  • Journal of the American Society of Nephrology

Their expertise is situated mainly within medical research, with a focus on innovative therapeutic approaches involving engineered antibodies and immune cell targeting.

Best Publications

  • Human antibodies derived from immunized xenomice

    Raju Kucherlapati;Aya Jakobovits;Daniel G. Brenner;Daniel J. Capon

  • Characterization of the human factor VIII gene

    Jane Gitschier;William I. Wood;Therese M. Goralka;Karen L. Wion

  • Complete nucleotide sequences of the T24 human bladder carcinoma oncogene and its normal homologue

    Daniel J. Capon;Ellson Y. Chen;Arthur D. Levinson;Peter H. Seeburg

  • Structure of human factor VIII.

    Gordon A. Vehar;Bruce Keyt;Dan Eaton;Henry Rodriguez

  • Delineation of a region of the human immunodeficiency virus type 1 gp120 glycoprotein critical for interaction with the CD4 receptor

    Laurence A. Lasky;Gerald Nakamura;Douglas H. Smith;Christopher Fennie

  • Nucleic acid structure and expression of the human AIDS/lymphadenopathy retrovirus.

    Mark A. Muesing;Douglas H. Smith;Cirilo D. Cabradilla;Charles V. Benton

  • Distinct primary structures, ligand-binding properties and tissue-specific expression of four human muscarinic acetylcholine receptors.

    E G Peralta;A Ashkenazi;J W Winslow;D H Smith

  • A Novel Phenotypic Drug Susceptibility Assay for Human Immunodeficiency Virus Type 1

    Christos J. Petropoulos;Neil T. Parkin;Kay L. Limoli;Yolanda S. Lie

  • Regulation of mRNA accumulation by a human immunodeficiency virus trans-activator protein

    Mark A. Muesing;Douglas H. Smith;Daniel J. Capon

  • Expression of active human factor VIII from recombinant DNA clones

    William I. Wood;Daniel J. Capon;Christian C. Simonsen;Dan L. Eaton

  • Designing CD4 immunoadhesins for AIDS therapy

    Daniel J. Capon;Steven M. Chamow;Joyce Mordenti;Scot A. Marsters

  • Comparative biochemical properties of normal and activated human ras p21 protein

    John P. McGrath;Daniel J. Capon;David V. Goeddel;Arthur D. Levinson

  • Recombinant human DNase I reduces the viscosity of cystic fibrosis sputum.

    Steven Shak;Daniel J. Capon;Renate Hellmiss;Scot A. Marsters

  • Generation of Xenogenetic antibodies

    Raju Kucherlapati;Aya Jakobovits;Sue Klapholz;Daniel G. Brenner

  • Blocking of HIV-1 infectivity by a soluble, secreted form of the CD4 antigen

    Douglas H. Smith;Randal A. Byrn;Scot A. Marsters;Timothy Gregory

  • Differential regulation of PI hydrolysis and adenylyl cyclase by muscarinic receptor subtypes

    Ernest G. Peralta;Avi Ashkenazi;Avi Ashkenazi;John W. Winslow;J. Ramachandran;J. Ramachandran

  • Biological properties of human c-Ha-ras1 genes mutated at codon 12

    Peter H. Seeburg;Wendy W. Colby;Daniel J. Capon;David V. Goeddel

  • Activation of ki-ras2 gene in human colon and lung carcinomas by two different point mutations

    Daniel J. Capon;Peter H. Seeburg;John P. McGrath;Joel S. Hayflick

  • Primary structure and biochemical properties of an M2 muscarinic receptor

    Ernest G. Peralta;John W. Winslow;Gary L. Peterson;Douglas H. Smith

  • Neutralization of the AIDS retrovirus by antibodies to a recombinant envelope glycoprotein.

    Laurence A. Lasky;Jerome E. Groopman;Christopher W. Fennie;Patricia M. Benz

Frequent Co-Authors

Laurence A. Lasky
Laurence A. Lasky The Column Group
David V. Goeddel
David V. Goeddel The Colum Group
Jerome E. Groopman
Jerome E. Groopman Beth Israel Deaconess Medical Center
Douglas H. Smith
Douglas H. Smith University of Pennsylvania
Florian M. Wurm
Florian M. Wurm École Polytechnique Fédérale de Lausanne
Dan L. Eaton
Dan L. Eaton Genentech

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Advancing your education in Biology and Biochemistry opens up a range of flexible, online options tailored to diverse career goals. For those passionate about nutrition science, consider exploring dietetics masters programs. These online degrees can lead to rewarding careers as registered dietitians or nutritionists.

If patient care interests you, start by reviewing financial aid for medical assistant programs. Many accredited schools offer online and affordable paths, helping students get started in the healthcare field without overwhelming debt.

Medical assistants seeking greater responsibility may benefit from a ma to lpn bridge program. These programs enable you to build on your experience and transition quickly to a Licensed Practical Nurse (LPN) role.

For those looking for speed and flexibility, consider online biology programs. Accelerated courses allow you to complete your degree faster, so you can move into research, laboratory, or clinical roles sooner.

Best Scientists Citing Daniel J. Capon

Trending Scientists

Recently Published Articles